- Home
- ELVA vs TLSA Comparison
ELVA vs TLSA Comparison
Compare ELVA & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVA
- TLSA
- Stock Information
- Founded
- ELVA 1996
- TLSA 2013
- Country
- ELVA Canada
- TLSA United Kingdom
- Employees
- ELVA N/A
- TLSA N/A
- Industry
- ELVA
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- ELVA
- TLSA Health Care
- Exchange
- ELVA Nasdaq
- TLSA Nasdaq
- Market Cap
- ELVA 91.8M
- TLSA 87.8M
- IPO Year
- ELVA N/A
- TLSA 2000
- Fundamental
- Price
- ELVA $2.60
- TLSA $1.02
- Analyst Decision
- ELVA Strong Buy
- TLSA
- Analyst Count
- ELVA 5
- TLSA 0
- Target Price
- ELVA $6.10
- TLSA N/A
- AVG Volume (30 Days)
- ELVA 67.5K
- TLSA 640.2K
- Earning Date
- ELVA 05-12-2025
- TLSA 05-09-2025
- Dividend Yield
- ELVA N/A
- TLSA N/A
- EPS Growth
- ELVA N/A
- TLSA N/A
- EPS
- ELVA N/A
- TLSA N/A
- Revenue
- ELVA $43,693,000.00
- TLSA N/A
- Revenue This Year
- ELVA $55.23
- TLSA N/A
- Revenue Next Year
- ELVA $63.75
- TLSA N/A
- P/E Ratio
- ELVA N/A
- TLSA N/A
- Revenue Growth
- ELVA N/A
- TLSA N/A
- 52 Week Low
- ELVA $1.67
- TLSA $0.41
- 52 Week High
- ELVA $3.58
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- ELVA 54.31
- TLSA 42.27
- Support Level
- ELVA $2.30
- TLSA $1.01
- Resistance Level
- ELVA $2.70
- TLSA $1.13
- Average True Range (ATR)
- ELVA 0.18
- TLSA 0.15
- MACD
- ELVA -0.00
- TLSA -0.05
- Stochastic Oscillator
- ELVA 48.37
- TLSA 8.82
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.